Better use of vaccines will reduce AMR deaths, report finds
Vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% every year, according to a new report by the World Health Organization (WHO).
While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible.
Antimicrobial resistance (AMR) is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly five million deaths are associated with AMR globally.
The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year.
An additional 543,000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
“Addressing antimicrobial resistance starts with preventing infections, and vaccines are among the most powerful tools for doing that,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Prevention is better than cure, and increasing access to existing vaccines and developing new ones for critical diseases, like tuberculosis, is critical to saving lives and turning the tide on AMR.”
Vaccines reduce antibiotic use
The report found that every year, vaccines against:
- Streptococcus pneumoniae could save 33 million antibiotic doses, if the Immunization Agenda 2030 target of 90% of the world’s children were vaccinated, as well as older adults.
- Typhoid could save 45 million antibiotic doses, if their introduction was accelerated in high-burden countries.
- Malaria caused by Plasmodium falciparum could save up to 25 million antibiotic doses, which are often misused to try to treat malaria.
- TB could have the highest impact once they are developed, saving between 1.2 to 1.9 billion antibiotic doses – a significant portion of the 11.3 billion doses used annually against the diseases covered in this report.
At the 79th United Nations General Assembly High-Level Meeting on AMR on 26 September, world leaders approved a political declaration committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial AMR annually by 10% by 2030.
The declaration emphasises the importance of access to vaccines, medicines, treatments and diagnostics, while calling for incentives and financing mechanisms to drive multisectoral health research, innovation and development in addressing AMR.
Diana Spencer, Senior Digital Content Editor, DDW
